Home > PJ (current issue) > CPD

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7445 p373-376
31 March 2007

This article
Reprint   Photocopy

PDF 170K, Acrobat Reader

Continuing professional development

Probiotics: are they worth taking?

Pamela Mason looks at the evidence for the benefits of ingesting “friendly bacteria”

Continuing professional development articles


Pamela Mason, PhD, MRPharmS, is a freelance journalist and author, based in Monmouthshire

Christopher Icha

Probiotic products

Claims on probiotic products include helping to support the body’s natural defences

SUMMARY

Probiotics are live cultures of micro-organisms, usually bacteria, that, when ingested, survive passage through the upper gastrointestinal tract and have beneficial effects on the host.

The most common bacteria used in probiotics include Lactobacillus species, bifidobacteria, some streptococci and other gram-positive cocci. These micro-organisms should resist gastric acid, bile salts and pancreatic enzymes, and adhere to and readily colonise the bowel where they displace potentially dangerous bacteria and create an environment that is unfavourable for the multiplication of such pathogens.

In the UK, probiotics are available in foods or food supplements, sometimes sold combined with prebiotics (see Panel 1), vitamins and minerals and digestive enzymes. However, in Italy, one probiotic product, a suspension of Bacillus subtilis spores manufactured by sanofi-aventis, has been available over the counter since 1999 for the treatment and prevention of gastrointestinal disorders. Increasingly popular, probiotics in the UK are consumed as fermented dairy products, such as yogurts and drinks, fruit juices, and dry preparations (ie, tablets, capsules and powders).

Uses suggested for probiotics include:

• To reduce the incidence and severity of diarrhoea
• To reduce the risk of allergic conditions
• To improve immune function
• To manage inflammatory bowel conditions, such as Crohn’s disease, ulcerative colitis and irritable bowel syndrome
• To prevent Helicobacter pylori gastritis
• To reduce symptoms of lactose intolerance
• To reduce vaginal infections
• To decrease blood cholesterol
• To protect against bowel cancer

Full article PDF 170K

Panel 1: Prebiotics

Prebiotics are non-digestible food substances that promote the growth of beneficial bacteria in the gastrointestinal tract. Chemically, prebiotics are oligosaccharides and examples include inulin-type fructans, fructooligosacharides and oligofructoses, which are present in many fruits and vegetables.

Prebiotics resist digestion in the upper part of the gastrointestinal tract and are fermented by endogenous anaerobic micro-organisms in the colon to produce lactic acid and short chain carboxylic acids (eg, acetic, butyric and propionic acid). This fermentation provides metabolic substrates to the cells of the colon, stimulating growth of the bifidobacteria population.

Prebiotics also promote the absorption of calcium and magnesium, and possibly other minerals and trace elements within the colon. Evidence is also emerging that they may reduce serum lipids, particularly triglycerides. They are also being investigated for a possible protective effect in bowel cancer, constipation, inflammatory bowel conditions, allergic dermatitis and lactose intolerance.

Back to Top


©The Pharmaceutical Journal